TruSpine Technologies plc (TSP) ORD GBP0.0001
- Add to watchlist
- This stock can be held in a
Business summary
Truspine Technologies Plc is a United Kingdom-based medical devices company. The Company is focused on the development of technologies to revolutionize the spinal stabilization market. The Company offers spinal fixation devices, such as Cervi-LOK, GRASP Laminoplasty and Faci-LOK. The Cervi-LOK is a screw free spinal stabilization system, used in the cervical spine that minimizes risk of vertebral artery injury, which can cause brainstem stroke or nerve root and spinal cord injury. The GRASP Laminoplasty system is used for the treatment of decompression of the spinal cord and does not require the use of any screws, thereby avoiding damage to the bony anatomy with respect to its fixation and anchoring. The Faci-LOK system is used for the lumbar and lower thoracic spine. Its Motion-LOK allows the surgeon the ability to either compress or distract based on the pathology affecting the patient, therefore providing segmental fixation.
Contact details
Important dates
General stock information
- EPIC:
- TSP
- ISIN:
- GB00BMZCKL55
- Market cap:
- £1.33 million
- Shares in issue:
- 120.31 million
- Sector:
- No specific industry
- Exchange:
- -
- Currency:
- Sterling pence
- Indices:
- n/a
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.